Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon W Moran

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
The American Journal of Gastroenterology|December 20, 2017
Corrigendum: Surgical Rates for Crohn's Disease Are Decreasing: A Population-Based Time Trend Analysis and Validation StudyChristopher Ma, Gordon W Moran, Eric I Benchimol, et al.
Alimentary Pharmacology & Therapeutics|August 17, 2023
Systematic review with meta-analysis: Medical therapies for treatment of ulcerative proctitisAchuthan Aruljothy, Siddharth Singh, Neeraj Narula, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 17, 2020
MR Measures of Small Bowel Wall T2 Are Associated With Increased PermeabilityRobert A Scott, Hannah G Williams, Caroline L Hoad, et al.
Nature Reviews. Gastroenterology & Hepatology|March 5, 2025
Developing an adaptive platform trial for evaluation of medical treatments for Crohn's diseaseNurulamin M Noor, Shellie J Radford, Babak Choodari-Oskooei, et al.
The American Journal of Clinical Nutrition|September 27, 2019
Gastrointestinal peptides and small-bowel hypomotility are possible causes for fasting and postprandial symptoms in active Crohn's diseaseAsseel Khalaf, Caroline L Hoad, Alex Menys, et al.
Scandinavian Journal of Gastroenterology|July 14, 2020
Experiences of using vedolizumab in the treatment of inflammatory bowel disease in the East Midlands UK - a retrospective observational studyJonathan R White, Said Din, Richard J M Ingram, et al.
BMJ Open Gastroenterology|February 10, 2023
BSG 2024 IBD guidelines protocol (standard operating procedures)Ana-Maria Darie, Vasiliki Sinopoulou, Verma Ajay, et al.
Journal of Crohn'S & Colitis|December 2, 2023
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResourceChristina Kapizioni, Rofaida Desoki, Danielle Lam, et al.
Journal of Crohn'S & Colitis|May 10, 2026
Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn's diseaseNurulamin M Noor, Haiyan Zheng, Zhi Cao, et al.
BMJ Open|November 24, 2025
Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca prospective IBD observational cohort studyAna Lilia Serna-Valverde, Eva Rodriguez-Suarez, Daniel J B Marks, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
The American Journal of Gastroenterology|December 20, 2017
Corrigendum: Surgical Rates for Crohn's Disease Are Decreasing: A Population-Based Time Trend Analysis and Validation StudyChristopher Ma, Gordon W Moran, Eric I Benchimol, et al.
Alimentary Pharmacology & Therapeutics|August 17, 2023
Systematic review with meta-analysis: Medical therapies for treatment of ulcerative proctitisAchuthan Aruljothy, Siddharth Singh, Neeraj Narula, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 17, 2020
MR Measures of Small Bowel Wall T2 Are Associated With Increased PermeabilityRobert A Scott, Hannah G Williams, Caroline L Hoad, et al.
Nature Reviews. Gastroenterology & Hepatology|March 5, 2025
Developing an adaptive platform trial for evaluation of medical treatments for Crohn's diseaseNurulamin M Noor, Shellie J Radford, Babak Choodari-Oskooei, et al.
The American Journal of Clinical Nutrition|September 27, 2019
Gastrointestinal peptides and small-bowel hypomotility are possible causes for fasting and postprandial symptoms in active Crohn's diseaseAsseel Khalaf, Caroline L Hoad, Alex Menys, et al.
Scandinavian Journal of Gastroenterology|July 14, 2020
Experiences of using vedolizumab in the treatment of inflammatory bowel disease in the East Midlands UK - a retrospective observational studyJonathan R White, Said Din, Richard J M Ingram, et al.
BMJ Open Gastroenterology|February 10, 2023
BSG 2024 IBD guidelines protocol (standard operating procedures)Ana-Maria Darie, Vasiliki Sinopoulou, Verma Ajay, et al.
Journal of Crohn'S & Colitis|December 2, 2023
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResourceChristina Kapizioni, Rofaida Desoki, Danielle Lam, et al.
Journal of Crohn'S & Colitis|May 10, 2026
Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn's diseaseNurulamin M Noor, Haiyan Zheng, Zhi Cao, et al.
BMJ Open|November 24, 2025
Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca prospective IBD observational cohort studyAna Lilia Serna-Valverde, Eva Rodriguez-Suarez, Daniel J B Marks, et al.
Pageof 7